Financial reports
10-K
2023 FY
Annual report
4 Mar 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2021 Q1
Quarterly report
28 Apr 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Ekso Bionics Reports Annual Revenue of $18.3 Million
4 Mar 24
8-K
Form of Securities Purchase Agreement
16 Jan 24
8-K
Financial Statements and Exhibits
10 Jan 24
8-K
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
4 Jan 24
8-K
Other Events
14 Nov 23
8-K
Achieves Record Quarter of EVO Unit Sales
26 Oct 23
8-K
Entry into a Material Definitive Agreement
29 Sep 23
8-K
Entry into a Material Definitive Agreement
18 Aug 23
8-K
Other Events
28 Jul 23
8-K
Ekso Bionics Report Record Revenues of $4.7 Million in Second Quarter 2023
27 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
18 Mar 24
424B5
Prospectus supplement for primary offering
11 Jan 24
424B5
Prospectus supplement for primary offering
28 Jul 23
S-8
Registration of securities for employees
12 Jun 23
S-3
Shelf registration
12 Jun 23
S-8
Registration of securities for employees
29 Mar 23
S-8
Registration of securities for employees
19 Jul 22
S-8
Registration of securities for employees
25 Feb 22
S-8
Registration of securities for employees
25 Feb 21
S-8
Registration of securities for employees
25 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
12 Nov 20
DEF 14A
Definitive proxy
12 Nov 20
DEF 14A
Definitive proxy
10 Feb 20
PRE 14A
Preliminary proxy
29 Jan 20
Other
EFFECT
Notice of effectiveness
21 Jun 23
CORRESP
Correspondence with SEC
15 Jun 23
UPLOAD
Letter from SEC
15 Jun 23
EFFECT
Notice of effectiveness
14 Jul 20
CORRESP
Correspondence with SEC
9 Jul 20
UPLOAD
Letter from SEC
9 Jul 20
EFFECT
Notice of effectiveness
8 Jul 20
CORRESP
Correspondence with SEC
25 Jun 20
UPLOAD
Letter from SEC
23 Jun 20
SEC STAFF
SEC staff action: Order
3 Oct 19
Ownership